GRAY PHARMA CONSULTING LIMITED

Company number 10227353 ·

Active

Net assets, total assets & total liabilities 2017 – 2026

  • Total assets
  • Net assets
  • Total liabilities
-£50k £0 £50k £100k £150k £200k £250k £300k 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Total assets 2017: £172,413 Total assets 2018: £226,756 Total assets 2019: £279,517 Total assets 2020: £220,594 Total assets 2021: £193,011 Total assets 2022: £186,130 Total assets 2023: £200,470 Total assets 2024: £253,058 Total assets 2025: £249,898 Total assets 2026: £248,687 Total assets Net assets 2017: £134,011 Net assets 2018: £181,280 Net assets 2019: £247,698 Net assets 2020: £216,041 Net assets 2021: £177,234 Net assets 2022: £172,108 Net assets 2023: £193,986 Net assets 2024: £238,786 Net assets 2025: £247,439 Net assets 2026: £247,844 Net assets Total liabilities 2017: -£34,725 Total liabilities 2018: -£28,772 Total liabilities 2019: -£17,288 Total liabilities 2020: -£1,708 Total liabilities 2021: -£13,880 Total liabilities 2022: -£13,079 Total liabilities 2023: -£6,319 Total liabilities 2024: -£14,272 Total liabilities 2025: -£2,459 Total liabilities 2026: -£843 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2026

0 1 2 3 4 5 6 2024 2025 2026 2024: 6 2025: 6 2026: 6

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 10 years

Latest accounts (2026-06-30): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2026-06-30 £248,687 -£843 £247,844 6
2025-06-30 £249,898 -£2,459 £247,439 6
2024-06-30 £253,058 -£14,272 £238,786 6
2023-06-30 £200,470 -£6,319 £193,986
2022-06-30 £186,130 -£13,079 £172,108
2021-06-30 £193,011 -£13,880 £177,234
2020-06-30 £220,594 -£1,708 £216,041
2019-06-30 £279,517 -£17,288 £247,698
2018-06-30 £226,756 -£28,772 £181,280 £207,785
2017-06-30 £172,413 -£34,725 £134,011 £150,397

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.